Abstract | BACKGROUND: AIMS: To evaluate the prevalence of sustained response and to determine the predictors of response to chronic hepatitis C therapy, in a cohort of outpatients at Curitiba, PR, south Brazil, in a setting of heterogeneous therapy regarding type and supply of the medications. POPULATION AND METHODS: RESULTS: A sustained response prevalence of 32.1% was found, positively associated to genotypes 2 and 3. CONCLUSIONS: Despite the frequent changes on product type and/or procedence, the sustained response prevalence rate found in this study was similar to that described in the literature.
|
Authors | Rafael Nastás Acras, Maria Lúcia A Pedroso, Leiber Carvalho Caum, Júlio C Pisani, Heda M B S Amarante, Eliane R Carmes |
Journal | Arquivos de gastroenterologia
(Arq Gastroenterol)
2004 Jan-Mar
Vol. 41
Issue 1
Pg. 3-9
ISSN: 0004-2803 [Print] Brazil |
Vernacular Title | A taxa de resposta sustentada da hepatite C crônica ao tratamento com os diversos interferons-alfa e ribavirinas distribuídos pelo governo brasileiro é semelhante à da literatura mundial. |
PMID | 15499417
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antiviral Agents
- Interferon-alpha
- Ribavirin
|
Topics |
- Adult
- Antiviral Agents
(therapeutic use)
- Brazil
- Cohort Studies
- Drug Therapy, Combination
- Fibrosis
- Genotype
- Government Programs
- Hepatitis C, Chronic
(drug therapy, genetics)
- Humans
- Interferon-alpha
(therapeutic use)
- Liver
(pathology)
- Male
- Predictive Value of Tests
- Ribavirin
(therapeutic use)
- Treatment Outcome
|